Compare Hamilton Storage Technologies vs Knopp Biosciences
Customers evaluate the quality of Hamilton Storage Technologies's products using the following success metrics.
Overview
Hamilton Storage Technologies is 42 yrs old and is based in United States.
Founded in 1998, and headquartered in Hopkinton, Massachusetts, Hamilton Storage Technologies, Inc. has a commitment to improve Life Science process management. The company envisioned improving customer efficiency by automating manual processes and integrating isolated upstream and downstream applications that plagued sample management in drug discovery. The company recognized the need for vigorous environmental control during processing to ensure compound integrity and increase data quality and operational effectiveness. The company's success is driven by a passion for understanding customer needs and a commitment to deliver solutions that aim to provide lasting value. With the company's market experience, strong customer networks, and automation expertise, the company developed modular, scalable systems that automate sample storage, management, and processing. Hamilton Storage Technologies aims to provide all the benefits of advanced automation, without the complexity associated with installing, operating, and maintaining large-scale custom systems. The company design the company's products to be easily integrated into existing lab infrastructure and processes with minimal disruption. The company's systems provide researchers unparalleled flexibility and security, while delivering to the lab dramatic improvements in efficiency and effectiveness.
Knopp Biosciences is 20 yrs old and is based in United States.
Knopp Biosciences is a drug discovery and development company focused on delivering treatments for unmet medical needs through experience and partnership. The company's clinical and preclinical programs focus on mechanisms of mitochondrial energetics and its lead compound, dexpramipexole, is currently in Phase 3 clinical development for amyotrophic lateral sclerosis. Additional programs include dexpramipexole combination therapy for Parkinson's disease and the discovery of ion channel modulators for pain and epilepsy.
Demo Video
Leadership
Gregory T. Hebrank (Executive Vice President)
Investors
Magellan Biosciences
National Institutes of Health, Pilot House Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Hamilton Storage Technologies has not claimed their profile.
Work for Hamilton Storage Technologies? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Hamilton Storage Technologies?
Claim your profile now.
Information not available because Knopp Biosciences has not claimed their profile.
Work for Knopp Biosciences? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Knopp Biosciences?
Claim your profile now.